Abstract / Summary
Heart failure (HF) is a global health burden with high mortality. Sudden cardiac death (SCD) remains a major complication, highlighting the need for accurate risk prediction. We conducted a systematic review and meta-analysis, guided by the Population, Intervention, Comparator, Outcome, Timing, and Setting framework, to identify risk factors for SCD in HF and assess prediction models. Searches across 8 databases yielded eligible studies. Data extraction, risk of bias assessment using the Prediction Model Risk of Bias Assessment Tool, and statistical analyses were performed. Twelve studies met inclusion criteria, with 8 included in the meta-analysis. New York Heart Association classification and left ventricular ejection fraction emerged as the most robust predictors of SCD. Additional significant factors included age, sex, ischemic etiology, diabetes, heart rate, sodium, potassium, creatinine, estimated glomerular filtration rate, and hemoglobin. Considerable heterogeneity was observed among studies. New York Heart Association class and left ventricular ejection fraction are key predictors of SCD in HF, while demographic, etiological, and laboratory factors further refine risk assessment. Current models show limitations due to heterogeneity and lack of external validation. Future work should integrate refined predictors, treatment responses, and diverse populations to improve the accuracy and clinical utility of SCD risk stratification in HF.
Topics
Primary Source
Medicine
Ask Prognia AI
Have questions about this meta-analysis?
Prognia AI can search this source alongside 35M+ PubMed papers and current ESC, AHA, NICE, and ADA guidelines to give you a fully cited clinical answer.
Related Clinical Guidelines
Related Blog Posts
ESC 2023 Heart Failure Guidelines: What Every Cardiologist Needs to Know
The 2023 focused update to the ESC Heart Failure Guidelines introduced key changes to SGLT2 inhibitor recommendations, HFmrEF management, and device therapy thresholds. Here is a practical summary.
CHADS₂-VASc in Practice: When to Start Anticoagulation in AF
A practical walkthrough of the CHADS₂-VASc scoring system, its ESC guideline thresholds, and how to use it alongside HAS-BLED to counsel patients with atrial fibrillation.